Page last updated: 2024-10-29

avapro and Dermatitis Medicamentosa

avapro has been researched along with Dermatitis Medicamentosa in 3 studies

Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gambini, D1
Sala, F1
Gianotti, R1
Cusini, M1
Pfab, F1
Athanasiadis, GI1
Kollmar, A1
Ring, J1
Ollert, M1
Constable, S1
Farrell, J1
Naisbitt, D1
King, C1
Leonard, N1
Pirmohamed, M1

Other Studies

3 other studies available for avapro and Dermatitis Medicamentosa

ArticleYear
Exanthematous reaction to irbesartan.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2003, Volume: 17, Issue:4

    Topics: Aged; Biopsy, Needle; Biphenyl Compounds; Drug Eruptions; Drug Therapy, Combination; Exanthema; Foll

2003
Lichenoid drug eruption due to an antihypertonic drug containing irbesartan and hydrochlorothiazide.
    Allergy, 2006, Volume: 61, Issue:6

    Topics: Aged; Angiotensin II; Antihypertensive Agents; Biphenyl Compounds; Drug Combinations; Drug Eruptions

2006
Systemic illness with skin eruption, fever and positive lymphocyte transformation test in a patient on irbesartan.
    The British journal of dermatology, 2006, Volume: 155, Issue:2

    Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Biphenyl Compounds; Drug Eruptions; Drug Hypersensiti

2006